EDGAR Filing Documents for 0001171843-21-002976

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001171843-21-002976

Filing Date

2021-04-30

Accepted

2021-04-30 16:25:19

Documents

Period of Report

2021-06-16

Document Format Files

Seq	Description	Document	Type	Size
1	DEF 14A	def14a_042921.htm	DEF 14A	1193896
2	GRAPHIC	blanchard.jpg	GRAPHIC	5683
3	GRAPHIC	blanchard_sig.jpg	GRAPHIC	3334
4	GRAPHIC	colleran.jpg	GRAPHIC	2577
5	GRAPHIC	envelope.jpg	GRAPHIC	2497
6	GRAPHIC	henneman.jpg	GRAPHIC	4501
7	GRAPHIC	land.jpg	GRAPHIC	5116
8	GRAPHIC	laptop.jpg	GRAPHIC	1819
9	GRAPHIC	larsen.jpg	GRAPHIC	4755
10	GRAPHIC	logo.jpg	GRAPHIC	13909
11	GRAPHIC	p31.jpg	GRAPHIC	73237
12	GRAPHIC	p3a.jpg	GRAPHIC	17609
13	GRAPHIC	p3b.jpg	GRAPHIC	18976
14	GRAPHIC	p3c.jpg	GRAPHIC	12884
15	GRAPHIC	p64.jpg	GRAPHIC	74850
16	GRAPHIC	p8.jpg	GRAPHIC	30965
17	GRAPHIC	phone.jpg	GRAPHIC	1664
18	GRAPHIC	proxy_01.jpg	GRAPHIC	135006
19	GRAPHIC	proxy_02.jpg	GRAPHIC	143652
20	GRAPHIC	richard.jpg	GRAPHIC	4557
21	GRAPHIC	thompson.jpg	GRAPHIC	4924
22	GRAPHIC	vogt.jpg	GRAPHIC	5389
	Complete submission text file	0001171843-21-002976.txt		1973780

Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730

Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000

Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)